지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Clinical and Molecular Hepatology
2022 .10
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2021 .01
The growing burden of non-alcoholic fatty liver disease on mortality
Clinical and Molecular Hepatology
2023 .04
Implications of comorbidities in nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Clinical and Molecular Hepatology
2021 .01
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Clinical and Molecular Hepatology
2023 .04
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Clinical and Molecular Hepatology
2023 .01
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Clinical and Molecular Hepatology
2022 .10
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Clinical and Molecular Hepatology
2023 .04
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease
Journal of Obesity & Metabolic Syndrome
2020 .01
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Clinical and Molecular Hepatology
2023 .04
0